Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report)’s stock price dropped 8.2% on Monday . The company traded as low as $9.7750 and last traded at $9.7750. Approximately 100 shares changed hands during trading, a decline of 85% from the average daily volume of 689 shares. The stock had previously closed at $10.65.
Ambu A/S Price Performance
The business has a 50 day moving average of $10.86 and a 200 day moving average of $12.74. The company has a market cap of $2.30 billion, a PE ratio of 34.91 and a beta of 1.06. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 EPS for the quarter. Ambu A/S had a return on equity of 8.13% and a net margin of 7.81%.The company had revenue of $246.39 million during the quarter.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Featured Stories
- Five stocks we like better than Ambu A/S
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
